VanEck Associates’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,937
Closed -$892K 1422
2021
Q4
$892K Buy
9,937
+4,120
+71% +$350K ﹤0.01% 873
2021
Q3
$450K Buy
5,817
+41
+0.7% +$3.08K ﹤0.01% 930
2021
Q2
$413K Sell
5,776
-58
-1% -$4.22K ﹤0.01% 923
2021
Q1
$395K Sell
5,834
-13,140
-69% -$911K ﹤0.01% 885
2020
Q4
$1.39M Buy
18,974
+1,862
+11% +$135K ﹤0.01% 606
2020
Q3
$1.2M Sell
17,112
-8,812
-34% -$691K ﹤0.01% 602
2020
Q2
$1.89M Sell
25,924
-4,020
-13% -$286K 0.01% 497
2020
Q1
$1.85M Buy
29,944
+1,125
+4% +$68.7K 0.01% 468
2019
Q4
$1.89M Buy
28,819
+1,721
+6% +$118K 0.01% 523
2019
Q3
$2.14M Buy
27,098
+2,173
+9% +$145K 0.01% 472
2019
Q2
$1.44M Buy
24,925
+528
+2% +$30.9K 0.01% 519
2019
Q1
$1.28M Buy
24,397
+979
+4% +$51.2K 0.01% 523
2018
Q4
$1.24M Buy
23,418
+2,005
+9% +$115K 0.01% 511
2018
Q3
$1.36M Buy
21,413
+1,510
+8% +$97.7K 0.01% 523
2018
Q2
$1.16M Buy
+19,903
New +$1.08M 0.01% 535

Other funds holding CONE

VanEck Associates's CONE Position: Q1 2022 in Review

VanEck Associates sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 9,937 shares — an estimated $892K sold.

VanEck Associates first reported a position in CONE in Q2 2018 and held it in 15 quarters. The position peaked at $2.14M in Q3 2019. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • VanEck Associates reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • VanEck Associates sold 9,937 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $892K.
  • VanEck Associates first reported a position in CyrusOne Inc Common Stock in Q2 2018 and held it in 15 quarters.
  • VanEck Associates's CyrusOne Inc Common Stock position peaked at $2.14M in Q3 2019.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on VanEck Associates's 13F filing for Q1 2022, filed 10 May 2022.